SFP
CRL icon

Sterling Financial Planning’s Charles River Laboratories CRL Stock Holding History

Sterling Financial Planning’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-745
Closed -$212K – 91
2022
Q1 		$212K Hold
745
– – 0.13% 89
2021
Q4 		$281K Buy
745
+45
+6% +$17.5K 0.18% 80
2021
Q3 		$289K Buy
700
+300
+75% +$125K 0.18% 68
2021
Q2 		$148K Buy
+400
New +$134K 0.1% 97

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sterling Financial Planning's CRL Position: Q2 2022 in Review

Sterling Financial Planning sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 745 shares — an estimated $212K sold.

Sterling Financial Planning first reported a position in CRL in Q2 2021 and held it in 4 quarters. The position peaked at $289K in Q3 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • Sterling Financial Planning reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
  • Sterling Financial Planning sold 745 Charles River Laboratories shares in Q2 2022, an estimated $212K.
  • Sterling Financial Planning first reported a position in Charles River Laboratories in Q2 2021 and held it in 4 quarters.
  • Sterling Financial Planning's Charles River Laboratories position peaked at $289K in Q3 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Sterling Financial Planning's 13F filing for Q2 2022, filed 27 Jul 2022.